Molecular defects in coagulation Factor VIII and their impact on Factor VIII function

Autor: Saenko, E. L., Ananyeva, N., Kouiavskaia, D., Schwinn, H., Josic, D., Shima, M., Hauser, C. A. E., Pipe, S.

Molecular defects in Factor VIII (FVIII), such as haemophilia A‐related mutations or denaturative conformational changes, may affect the stability of FVIII as well as its interactions with physiological activators, von Willebrand Factor, phospholip

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::9829d3f0ad0e30adbab22263676eaddc
https://doi.org/10.1046/j.1423-0410.2002.00183.x

Neurosteroids: molecular mechanisms of action and psychopharmacological significance

Autor: Rupprecht, R., Hauser, C. A. E., Trapp, T., Holsboer, F.

Publikováno v: Journal of Steroid Biochemistry and Molecular Biology; 1996, Vol. 56 Issue: 1 p163-168, 6p

Efficient factor VIII affinity purification using a small synthetic ligand.

Autor: Knör S; Center of Integrated Protein Science, Munich, at Department Chemie, Lehrstuhl II für Organische Chemie, Technische Universität München, Garching, Germany., Khrenov A, Laufer B, Benhida A, Grailly SC, Schwaab R, Oldenburg J, Beaufort N, Magdolen V, Saint-Remy JM, Saenko EL, Hauser CA, Kessler H

Publikováno v: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2008 Mar; Vol. 6 (3), pp. 470-7. Date of Electronic Publication: 2008 Jan 09.